TERT and melanoma: On the basis of the results described above, we hypothesized that combining a mitochondria disrupting agent with 6-thio-dG or TERT depletion could kill NRAS-mutant melanoma cells by concurrently inducing high levels of ROS and blocking the antioxidant adaptive program trigerred by telomere dysfunction.